Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Principles of Disease Surveillance01:26

Principles of Disease Surveillance

593
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
593
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

934
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
934
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

945
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
945
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.6K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.6K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

3.2K
The pathophysiology of pneumonia involves the following steps:
3.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

838
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
838

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality indicators for appropriate inpatient antibiotic use: results from two national surveys in Italy, 2016-2022.

The Journal of hospital infection·2025
Same author

Tools and strategies for monitoring hospital environmental hygiene services.

The Journal of hospital infection·2025
Same author

Inverse probability weighting leads to more accurate incidence estimates for healthcare-associated infections in intensive care units - results from two national surveillance systems.

The Journal of hospital infection·2024
Same author

Impact of COVID-19 on healthcare-associated infections and antimicrobial use in Italy, 2022.

The Journal of hospital infection·2024
Same author

The intertwining of healthcare-associated infections and COVID-19 in Italian intensive care units: an analysis of the SPIN-UTI project from 2006 to 2021.

The Journal of hospital infection·2023
Same author

Differences in the incidence and clinical outcomes of SARS-CoV-2 infection between Italian and non-Italian nationals using routine data.

Public health·2022

Related Experiment Video

Updated: Feb 17, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K

Pneumococcal disease surveillance in Europe.

R G Pebody1, W Hellenbrand2, F D'Ancona3

  • 1Health Protection Agency Centre for Infections, London, United Kingdom.

Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|December 7, 2017
PubMed
Summary

Invasive pneumococcal disease (IPD) surveillance across Europe is highly varied, with many countries lacking robust systems. Strengthening surveillance is crucial for informed decisions on pneumococcal vaccines.

Keywords:
invasive pneumococcal diseasesurveillancevaccines and immunisation

More Related Videos

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

16.3K
Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

2.2K

Related Experiment Videos

Last Updated: Feb 17, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K
Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

16.3K
Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

2.2K

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Diseases

Background:

  • Pneumococcal disease (Pnc) causes invasive pneumococcal disease (IPD), a significant public health concern in Europe.
  • Several European nations are implementing universal childhood immunization programs with pneumococcal conjugate vaccines (PCV).

Purpose of the Study:

  • To assess the current state of national surveillance systems for invasive pneumococcal disease (IPD) across European Union member states and associated countries.
  • To identify variations and gaps in IPD surveillance methodologies and data collection.

Main Methods:

  • A questionnaire was distributed in 2003 to 27 European countries and Norway/Switzerland, with follow-up updates in 2006.
  • Data on surveillance systems, case definitions, laboratory testing, and vaccine status collection were analyzed from 22 responding countries.

Main Results:

  • IPD surveillance systems were reported by 18 of 22 countries, but case definitions and data collection varied significantly.
  • Only 5 out of 27 systems collected data on pneumococcal conjugate vaccine status.
  • Reported IPD incidence ranged from 0.4 to 20 per 100,000 population, with 23,470 cases reported over 12 months.

Conclusions:

  • European surveillance for invasive pneumococcal disease is heterogeneous, with several countries lacking adequate systems.
  • Strengthening IPD surveillance is essential for effective decision-making regarding new pneumococcal vaccines and monitoring program impact.